About this trial
Epilepsy affects nearly 600,000 people in France and causes neurological seizures that can lead to lasting impairments and stigma. Physical activity provides many benefits, including improved quality of life, social participation, and reduced stress and seizure frequency. Despite these benefits, people with epilepsy tend to be less active than the general population due to barriers such as fear of seizures during exercise, fatigue, and negative beliefs about the disease. Psychological factors and stigma influence physical activity engagement and affect how the disease is integrated into personal identity, impacting quality of life and treatment adherence. Studying the role of anxiety, stigma, and illness identity, as well as their interaction with physical activity identity, is essential to better understand and promote physical activity among people with epilepsy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals self-reporting as over 18 years old
Individuals self-reporting having epilepsy
Disqualifiers
not having completed secondary questionnaire at 6 months from inclusion
Trial population
Epileptic person willing to complete an online questionnaire about their physical activity
Trial design
Cohort
Prospective
Treatments tested in this trial
online questionnaire
BehavioralOnline questionnaire assessing physical activity level, completed twice at a 6-month interval.
Treatment groups
Trial outcomes
Primary outcomes
maintained physical activity
Physical activity level will be measured using an adapted version of the Modifiable Activity Questionnaire (MAQ) at inclusion and 6 months later as a criterion for behavior maintenance. MAQ ranges starts from 0 with no maximum limit. A higher value means a higher physical activity level.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.